Open access
2025
Journal of Population Therapeutics and Clinical Pharmacology
Dual antiplatelet therapy (DAPT)—a combination of two antiplatelet agents—is sometimes prescribed for high-risk patients to provide greater protection against recurrent strokes, but balancing the benefits of stroke prevention with the risk of bleeding complications remains a clinical challenge.
Deepak Kumar Punna, Sumana Chatla, A. K. Sharma et al.
· 0 citations